Convergent functional genomic (CFG) is a method aiming at prioritizing AD candidate genes. CFG integrates AD related evidence including:
1) Genetic association of DNA variations with disease susceptibility;
2) gene expression regulated by AD genetic variants;
3) protein-protein interaction with AD core proteins, i.e. APP, PSEN1, PSEN2, APOE and MAPT;
4) diagnosis prediction of disease models.
Lambert et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature genetics, 45(12): 1452-1458 (2013).
Colantuoni et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature, 478(7370): 519-523 (2011).
Itan et al. The human gene connectome as a map of short cuts for morbid allele discovery. Proceedings of the National Academy of Sciences, 110(14): 5558-5563 (2013).
Matarin et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell reports, 10(4): 633-644 (2015).
Copyright©2016-2018 Kunming Institute of Zoology, Chinese Academy of Sciences. All Rights Reserved.